WHO Regional Office for Europe. Avoidable mortality, risk factors and policies for tackling noncommunicable diseases – leveraging data for impact: monitoring commitments in the WHO European Region ahead of the Fourth United Nations High-Level Meeting. Copenhagen, 2025.
2.
The Lancet. The dialogue around NCDs needs to change. Lancet2025; 406(10506): 885.
3.
ThorntonJ.Robert F Kennedy Jr torpedoes UN declaration on non-communicable diseases. BMJ2025; 390: r2033.
4.
GilmoreABFabbriABaumF, et al. Defining and conceptualising the commercial determinants of health. Lancet2023; 401(10383): 1194-213.
5.
van SchalkwykMCIMaaniNHawkinsBPetticrewMBuseK.Reclaiming the narrative: countering harmful commercial discourses. Health Promotion International2024; 39(6).
6.
van den AkkerAGilmoreABFabbriAKnaiCRutterH.Aligning rhetoric with reality: a qualitative analysis of multistakeholder initiatives in the global food system. Health Promotion International2024; 39(6).
7.
WHO Regional Office for Europe. Commercial determinants of noncommunicable diseases in the WHO European Region. Copenhagen, 2024.
8.
HunterDPopayJTannahillCWhiteheadMElsonT.Learning Lessons from the Past: Shaping a Different Future, 2009.
9.
PopayJWhiteheadMHunterDJ.Injustice is killing people on a large scale—but what is to be done about it?Journal of Public Health2010; 32(2): 148-9.
10.
VellekoopHVersteeghMHuygensS, et al. The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis. Value in Health2022; 25(8): 1428-38.
11.
FarinaSOstiTRussoL, et al. The current landscape of personalised preventive approaches for non-communicable diseases: A scoping review. PLOS ONE2025; 20(1): e0317379.
12.
GolinelliDPecoraroVTedescoD, et al. Population risk stratification tools and interventions for chronic disease management in primary care: a systematic literature review. BMC Health Services Research2025; 25(1): 526.
13.
MarmotMAtkinsonTBellJ, et al. Fair Society, Healthy Lives: The Marmot Review, 2010.
14.
SwinburnBEggerGRazaF.Dissecting obesogenic environments: the development and application of a framework for identifying and prioritizing environmental interventions for obesity. Prev Med1999; 29(6 Pt 1): 563-70.
15.
AdamsJMyttonOWhiteMMonsivaisP.Why Are Some Population Interventions for Diet and Obesity More Equitable and Effective Than Others? The Role of Individual Agency. PLOS Medicine2016; 13(4): e1001990.
16.
KleppKIHelleveAHøstrupE, et al. Scaling up non-communicable disease prevention and health promotion across Europe: The Joint Action PreventNCD. Scand J Public Health2025; 53(3S): 8-17.
17.
KleppK-IHelleveABrinsdenH, et al. Overweight and obesity prevention for and with adolescents: The “Confronting obesity: Co-creating policy with youth” (CO-CREATE) project. Obesity Reviews2023; 24(S1): e13540.
18.
World Health Organisation. Tackling NCDs: best buys and other recommended interventions for the prevention and control of noncommunicable diseases. Second edition ed. Geneva; 2024.
19.
MarteauTMWhiteMRutterH, et al. Increasing healthy life expectancy equitably in England by 5 years by 2035: could it be achieved?The Lancet2019; 393(10191): 2571-3.
